12-120994499-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000545.8(HNF1A):​c.955+94T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.442 in 1,404,666 control chromosomes in the GnomAD database, including 140,069 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.41 ( 13512 hom., cov: 32)
Exomes 𝑓: 0.45 ( 126557 hom. )

Consequence

HNF1A
NM_000545.8 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.568

Publications

37 publications found
Variant links:
Genes affected
HNF1A (HGNC:11621): (HNF1 homeobox A) The protein encoded by this gene is a transcription factor required for the expression of several liver-specific genes. The encoded protein functions as a homodimer and binds to the inverted palindrome 5'-GTTAATNATTAAC-3'. Defects in this gene are a cause of maturity onset diabetes of the young type 3 (MODY3) and also can result in the appearance of hepatic adenomas. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2015]
HNF1A Gene-Disease associations (from GenCC):
  • monogenic diabetes
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • type 1 diabetes mellitus 20
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp
  • diabetes mellitus, noninsulin-dependent
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • maturity-onset diabetes of the young type 3
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • hyperinsulinism due to HNF1A deficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • maturity-onset diabetes of the young
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • nonpapillary renal cell carcinoma
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 12-120994499-T-G is Benign according to our data. Variant chr12-120994499-T-G is described in ClinVar as Benign. ClinVar VariationId is 676860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.7 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HNF1ANM_000545.8 linkc.955+94T>G intron_variant Intron 4 of 9 ENST00000257555.11 NP_000536.6
HNF1ANM_001306179.2 linkc.955+94T>G intron_variant Intron 4 of 9 NP_001293108.2
HNF1ANM_001406915.1 linkc.955+94T>G intron_variant Intron 4 of 8 NP_001393844.1
HNF1AXM_024449168.2 linkc.955+94T>G intron_variant Intron 4 of 8 XP_024304936.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HNF1AENST00000257555.11 linkc.955+94T>G intron_variant Intron 4 of 9 1 NM_000545.8 ENSP00000257555.5

Frequencies

GnomAD3 genomes
AF:
0.410
AC:
62226
AN:
151940
Hom.:
13502
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.281
Gnomad AMI
AF:
0.522
Gnomad AMR
AF:
0.431
Gnomad ASJ
AF:
0.501
Gnomad EAS
AF:
0.720
Gnomad SAS
AF:
0.523
Gnomad FIN
AF:
0.475
Gnomad MID
AF:
0.544
Gnomad NFE
AF:
0.433
Gnomad OTH
AF:
0.431
GnomAD4 exome
AF:
0.446
AC:
558096
AN:
1252610
Hom.:
126557
AF XY:
0.448
AC XY:
275270
AN XY:
614938
show subpopulations
African (AFR)
AF:
0.272
AC:
7764
AN:
28574
American (AMR)
AF:
0.436
AC:
12810
AN:
29350
Ashkenazi Jewish (ASJ)
AF:
0.514
AC:
10608
AN:
20650
East Asian (EAS)
AF:
0.700
AC:
24490
AN:
34986
South Asian (SAS)
AF:
0.517
AC:
35059
AN:
67850
European-Finnish (FIN)
AF:
0.467
AC:
21308
AN:
45618
Middle Eastern (MID)
AF:
0.524
AC:
2687
AN:
5124
European-Non Finnish (NFE)
AF:
0.433
AC:
419447
AN:
967922
Other (OTH)
AF:
0.455
AC:
23923
AN:
52536
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
16735
33470
50206
66941
83676
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13000
26000
39000
52000
65000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.409
AC:
62258
AN:
152056
Hom.:
13512
Cov.:
32
AF XY:
0.417
AC XY:
30974
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.282
AC:
11677
AN:
41472
American (AMR)
AF:
0.431
AC:
6590
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.501
AC:
1739
AN:
3468
East Asian (EAS)
AF:
0.719
AC:
3721
AN:
5172
South Asian (SAS)
AF:
0.523
AC:
2526
AN:
4826
European-Finnish (FIN)
AF:
0.475
AC:
5027
AN:
10576
Middle Eastern (MID)
AF:
0.534
AC:
157
AN:
294
European-Non Finnish (NFE)
AF:
0.433
AC:
29428
AN:
67948
Other (OTH)
AF:
0.435
AC:
918
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1851
3701
5552
7402
9253
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
598
1196
1794
2392
2990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.418
Hom.:
24313
Bravo
AF:
0.399

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.59
DANN
Benign
0.37
PhyloP100
-0.57
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1169302; hg19: chr12-121432302; COSMIC: COSV57467159; COSMIC: COSV57467159; API